BCL2 and breast carcinoma: Beyond its role in intrinsic apoptosis, ZKSCAN3 also possesses the ability to activate the extrinsic apoptosis pathway, as evidenced by its activation of the Bcl2 signaling pathway and induction of apoptosis in bladder and breast cancer [32,40].